Peter Sorger
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
systems biology, cancerGoogle:
"Peter Sorger"Mean distance: 106866
Cross-listing: Computational Biology Tree
Children
Sign in to add trainee| Charles Tapley Hoyt | post-doc | 2021- | Harvard Medical School (Computational Biology Tree) |
| Alex Y. H. Wong | post-doc | 2023- | (Chemistry Tree) |
| Jeffrey L. Werbin | post-doc | 2010-2014 | Harvard Medical School (Chemistry Tree) |
| Ratul Chowdhury | post-doc | 2020-2022 | Harvard Medical School (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou FY, Yapp C, Shang Z, et al. (2024) A general algorithm for consensus 3D cell segmentation from 2D segmented stacks. Biorxiv : the Preprint Server For Biology |
| Yapp C, Nirmal AJ, Zhou F, et al. (2023) Multiplexed 3D Analysis of Cell Plasticity and Immune Niches in Melanoma. Biorxiv : the Preprint Server For Biology |
| Chowdhury R, Bouatta N, Biswas S, et al. (2022) Publisher Correction: Single-sequence protein structure prediction using a language model and deep learning. Nature Biotechnology. 40: 1692 |
| Chowdhury R, Bouatta N, Biswas S, et al. (2022) Single-sequence protein structure prediction using a language model and deep learning. Nature Biotechnology |
| Doherty LM, Mills CE, Boswell SA, et al. (2022) Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. Elife. 11 |
| Patiño-Galindo JÁ, Filip I, Chowdhury R, et al. (2021) Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2. Genome Medicine. 13: 124 |
| Rashid R, Gaglia G, Chen YA, et al. (2019) Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer. Scientific Data. 6: 323 |
| Gerosa L, Chidley C, Froehlich F, et al. (2019) Abstract LB-B09: ERK pulses drive non-genetic resistance in drug-adapted BRAFV600E melanoma cells Molecular Cancer Therapeutics. 18 |
| Mills C, Hafner M, Subramanian K, et al. (2018) Abstract PD1-12: Omics profiling of CDK4/6 inhibitors reveals functionally important secondary targets of abemaciclib Cancer Research. 16 |
| Hafner M, Mills C, Subramanian K, et al. (2018) Abstract PD4-02: Advantageous polypharmacology of abemaciclib revealed by omics profiling of CDK4/6 inhibitors Cancer Research. 78 |